Congo officials say Ebola vaccine passed in clinical trial

Officials of the Democratic Republic of Congo say that the recently developed Ebola vaccine has been started to combat Ebola. The country of Congo has been battling the Ebola virus that has caused the most harm to mankind for a long time. The new vaccine is produced by Johnson & Johnson. To combat the Ebola virus, this dose has to be taken 8 weeks per 2 injections daily. Health officials in the Democratic Republic of Congo have begun using a new vaccine to control the deadly Ebola virus outbreak. Global health NGO Medicine Sense Frontiers (MSF) gave information about this on Thursday. According to MSF, 50,000 dosages of AD26 ZEBOV / MVA-BN-Philo vaccine will be given in the health centers of two districts in Goma city.

Officials of the Democratic Republic of Congo say that the recently developed Ebola vaccine has been started to combat Ebola.

Ebola vaccine passed in clinical trial, Congo started vaccination in two districts
Ebola vaccine passed in clinical trial, Congo started vaccination in two districts

According to the information, MNF is assisting the Ministry of Health of the African nation in implementing the rollout. The organization stated that the primary objective of the rollout is to obtain data on the effectiveness of experimental vaccines in real-world settings. Clinical trial of the new vaccine has been done but its results are awaited on the patients in the real world. It has been proved in lab tests that this vaccine builds a strong immune system to fight the Ebola virus. The MSF says that Ebola has spread like an epidemic in our country and to avoid it, providing the best vaccine is the only option at the present time.

Facebook Comments